Ekaterina Korf

Mrs. Ekaterina Korf


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NGNikolay V. Goncharov
Nikolay V. Goncharov
PPPolina I. Popova
Polina I. Popova
Igor KudryavtsevIgor Kudryavtsev
Igor Kudryavtsev
AGAlexey Golovkin
Alexey Golovkin
ISIrina V. Savitskaya
Irina V. Savitskaya
PAPavel Avdonin
Pavel Avdonin
The process of aging is accompanied by a dynamic restructuring of the immune response, a phenomenon known as immunosenescence. Further, damage to the endothelium can be both a cause and a consequence of many diseases, especially in elderly people. The purpose of this study was to carry out immunological and biochemical profiling of elderly people with acute ischemic stroke (AIS), chronic cerebral circulation insufficiency (CCCI), prediabetes or newly diagnosed type II diabetes mellitus (DM), and subcortical ischemic vascular dementia (SIVD). Socio-demographic, lifestyle, and cognitive data were obtained. Biochemical, hematological, and immunological analyses were carried out, and extracellular vesicles (EVs) with endothelial CD markers were assessed. The greatest number of significant deviations from conditionally healthy donors (HDs) of the same age were registered in the SIVD group, a total of 20, of which 12 were specific and six were non-specific but with maximal differences (as compared to the other three groups) from the HDs group. The non-specific deviations were for the MOCA (Montreal Cognitive Impairment Scale), the MMSE (Mini Mental State Examination) and life satisfaction self-assessment scores, a decrease of albumin levels, and ADAMTS13 (a Disintegrin and Metalloproteinase with a Thrombospondin Type 1 motif, member 13) activity, and an increase of the VWF (von Willebrand factor) level. Considering the significant changes in immunological parameters (mostly Th17-like cells) and endothelial CD markers (CD144 and CD34), vascular repair was impaired to the greatest extent in the DM group. The AIS patients showed 12 significant deviations from the HD controls, including three specific to this group. These were high NEFAs (non-esterified fatty acids) and CD31 and CD147 markers of EVs. The lowest number of deviations were registered in the CCCI group, nine in total. There were significant changes from the HD controls with no specifics to this group, and just one non-specific with a maximal difference from the control parameters, which was α1-AGP (alpha 1 acid glycoprotein, orosomucoid). Besides the DM patients, impairments of vascular repair were also registered in the CCCI and AIS patients, with a complete absence of such in patients with dementia (SIVD group). On the other hand, microvascular damage seemed to be maximal in the latter group, considering the biochemical indicators VWF and ADAMTS13. In the DM patients, a maximum immune response was registered, mainly with Th17-like cells. In the CCCI group, the reaction was not as pronounced compared to other groups of patients, which may indicate the initial stages and/or compensatory nature of organic changes (remodeling). At the same time, immunological and biochemical deviations in SIVD patients indicated a persistent remodeling in microvessels, chronic inflammation, and a significant decrease in the anabolic function of the liver and other tissues. The data obtained support two interrelated assumptions. Taking into account the primary biochemical factors that trigger the pathological processes associated with vascular pathology and related diseases, the first assumption is that purine degradation in skeletal muscle may be a major factor in the production of uric acid, followed by its production by non-muscle cells, the main of which are endothelial cells. Another assumption is that therapeutic factors that increase the levels of endothelial progenitor cells may have a therapeutic effect in reducing the risk of cerebrovascular disease and related neurodegenerative diseases.

Verified
Journal Article
Open access
PDF file
DBDaria A. Belinskaia
Daria A. Belinskaia
PVPolina A. Voronina
Polina A. Voronina
PPPolina I. Popova
Polina I. Popova
NVNatalya Voytenko
Natalya Voytenko
VSVladimir I. Shmurak
Vladimir I. Shmurak
NGNikolay Goncharov
Nikolay Goncharov
The esterase status of blood plasma can claim to be one of the universal markers of various diseases; therefore, it deserves attention when searching for markers of the severity of COVID-19 and other infectious and non-infectious pathologies. When analyzing the esterase status of blood plasma, the esterase activity of serum albumin, which is the major protein in the blood of mammals, should not be ignored. The purpose of this study is to expand understanding of the esterase status of blood plasma and to evaluate the relationship of the esterase status, which includes information on the amount and enzymatic activity of human serum albumin (HSA), with other biochemical parameters of human blood, using the example of surviving and deceased patients with confirmed COVID-19. In experiments in vitro and in silico, the activity of human plasma and pure HSA towards various substrates was studied, and the effect of various inhibitors on this activity was tested. Then, a comparative analysis of the esterase status and a number of basic biochemical parameters of the blood plasma of healthy subjects and patients with confirmed COVID-19 was performed. Statistically significant differences have been found in esterase status and biochemical indices (including albumin levels) between healthy subjects and patients with COVID-19, as well as between surviving and deceased patients. Additional evidence has been obtained for the importance of albumin as a diagnostic marker. Of particular interest is a new index, [Urea] × [MDA] × 1000/(BChEb × [ALB]), which in the group of deceased patients was 10 times higher than in the group of survivors and 26 times higher than the value in the group of apparently healthy elderly subjects.

Verified
Journal Article
Open access
PDF file
DADaniil Artamonov
Daniil Artamonov
PPPolina I. Popova
Polina I. Popova
EKEkaterina Korf
Ekaterina Korf
NVNatalya Voytenko
Natalya Voytenko
ACAlisa Алексеевна Chernysheva
Alisa Алексеевна Chernysheva
NGNikolay V. Goncharov
Nikolay V. Goncharov
Vascular and metabolic disorders in the elderly—including acute ischemic stroke (AIS), chronic cerebral circulation insufficiency (CCCI), type 2 diabetes mellitus (DM), and subcortical ischemic vascular dementia (SIVD)—pose a major diagnostic challenge due to their reliance on multi-parameter blood chemistry. In this study, 49 biochemical features were analyzed within a cohort of 120 patients. The application of variance-aware statistical testing revealed that several features (e.g., Fe, Transf, RDW%, LDL) exhibited statistically significant heterogeneity of variance (p < 0.05), which is known to distort standard ANOVA inference. While standard machine-learning (ML) classifiers demonstrated variable performance across clinical groups, a gradient boosting model with restricted tree depth (max depth = 3) achieved high discriminative accuracy, yielding F1-scores between 0.87 and 0.96 across all five clinical classes. Through the use of Shapley Additive Explanations (SHAP), key stable biomarkers including iron (Fe), transferrin, and glucose were identified as having synergistic interactions in model predictions. A comparative analysis of feature importance ranks indicated consistency between statistical significance and SHAP values, with Spearman correlation coefficients reaching 0.53 for groups 1–2 and 0.59 for groups 1–5. Conversely, unsupervised KMeans clustering (k = 5) revealed a poor correspondence with clinical labels, yielding an Adjusted Rand Index (ARI) of 0.198 and Normalized Mutual Information (NMI) of 0.286. These results underscore that statistical structures in biochemical data do not always map to meaningful clinical categories and advocate for the adoption of variance-aware workflows and interpretable ML to enhance diagnostic reliability in aging populations.

18 December 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
NGNikolay Goncharov
Nikolay Goncharov
ESElena I. Savelieva
Elena I. Savelieva
TKTatiana Koneva
Tatiana Koneva
LGLyudmila K. Gustyleva
Lyudmila K. Gustyleva
IVIrina Vasileva
Irina Vasileva
RJRichard Jenkins
Richard Jenkins
Background/Objectives: The delayed effects of organophosphate poisoning may manifest years after exposure, often masked by age-related diseases. The aim of this retrospective cohort study was to identify the biochemical “trace” that could remain in patients decades after poisoning. We determined a wide range of biochemical parameters, along with the spectrum of esterified and non-esterified fatty acids (EFAs and NEFAs, respectively), in the blood plasma of a cohort of elderly patients diagnosed with occupational pathology (OP) due to (sub)chronic exposure to organophosphates in the 1980s. Methods: Elderly patients with and without a history of exposure to organophosphates were retrospectively divided into two groups: controls (n = 59, aged 73 ± 4, men 29% and women 71%) and those with OP (n = 84, aged 74 ± 4, men 29% and women 71%). The period of neurological examination and blood sampling for subsequent analysis was from mid-2022 to the end of 2023. Determination of the content of biomarkers of metabolic syndrome, NEFAs, and EFAs in blood plasma was performed by HPLC-MS/MS and GC-MS. Results: The medical histories of the examined elderly individuals with OP and the aged control group included common age-related diseases. However, patients with OP more often had hepatitis, gastrointestinal diseases, polyneuropathy, and an increased BMI. Analysis of metabolic biomarkers revealed, in the OP group, a decrease in the concentrations of 3-hydroxybutyrate (p < 0.05), 2-hydroxybutyrate (p < 0.0001), and acetyl-L-carnitine (p < 0.001) and the activity of butyrylcholinesterase (BChE) (p < 0.05), but an increase in the esterase activity of albumin (p < 0.05). Correlation analysis revealed significant relationships between albumin esterase activity and arachidonic acid concentrations in the OP group (0.64, p < 0.0001). A study of a wide range of fatty acids in patients with OP revealed reciprocal relationships between EFAs and NEFAs. A statistically significant decrease in concentration was shown for esters of margaric, stearic, eicosadienoic, eicosatrienoic, arachidonic, eicosapentaenoic, and docosahexaenoic fatty acids. A statistically significant increase in concentration was shown for non-esterified heptadecenoic, eicosapentaenoic, eicosatrienoic, docosahexaenoic, γ-linolenic, myristic, eicosenoic, arachidonic, eicosadienoic, oleic, linoleic, palmitic, linoelaidic, stearic, palmitoleic, pentadecanoic, and margaric acids. Decreases in the ratios of omega-3 to other unsaturated fatty acids were observed only for the esterified forms. Conclusions: The data obtained allow us to consider an increased level of NEFAs as one of the main cytotoxic factors for the vascular endothelium. Modification of albumin properties and decreased bioavailability of docosahexaenoic acid could be molecular links that cause specific manifestations of organophosphate-induced pathology at late stages after exposure.

12 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
NGNikolay Goncharov
Nikolay Goncharov
ESElena I. Savelieva
Elena I. Savelieva
TKTatiana Koneva
Tatiana Koneva
LGLyudmila K. Gustyleva
Lyudmila K. Gustyleva
IVIrina Vasileva
Irina Vasileva
RJRichard Jenkins
Richard Jenkins
Background/Objectives: The delayed effects of subchronic and chronic organophosphate poisoning may manifest years after exposure, often masked by age-related diseases. The aim of this retrospective cohort study was to identify the biochemical "trace" that could remain in the patients decades after the poisoning. To achieve this goal, we determined a wide range of biochemical parameters, along with the spectrum of esterified and non-esterified fatty acids (EFA and NEFA, respectively), in the blood plasma of a cohort of elderly patients diagnosed with occupational pathology (OP) due to subacute or (sub)chronic exposure to organophosphates in the 1980s. Methods: Elderly patients with and without a history of exposure to organophosphates were retrospectively divided into two groups: controls (n=59, aged 73±4, men 29% and women 71%) and having the OP (n=84, aged 74±4, men 29% and women 71%). The period of neurological examination and blood sampling for subsequent analysis was approximately one and a half years - from mid-2022 to the end of 2023. Determination of the content of biomarkers of metabolic syndrome, NEFA and EFA in blood plasma was performed by HPLC-MS/MS and GC-MS. Results: The medical history of the examined elderly individuals with OP and the aged control group includes common age-related diseases. However, patients with OP more often have hepatitis (33 vs 7%, p<0.001) and other gastrointestinal diseases (54 vs 32%, p<0.05), total with diagnosis of polyneuropathy (87 vs 66%, p<0.01) and polyneuropathy of the upper and lower extremities (29 vs 12%, p<0.05), impaired distal sensitivity (83 vs 56%, p<0.001), increased body mass index (30.0±4.6 vs 28.4±4.1, p<0.05), and also they have an increased drug load (5 vs 4, p<0.001). Patients with OP more often have balance problems (84 vs 69%, p<0.05) and difficulties in performing daily activities (75 vs 49%, p<0.01). No differences were found between the groups when assessing cognitive function using the MMSE (mini mental state examination), SAGE (self-administered gerocognitive exam), and “Clock” tests. Of the 34 basic biochemical parameters determined on the biochemical analyzer, statistically significant changes were found for only 11, with their median values not going beyond the reference range (clinical norm), and the differences being due to significant individual deviations. Analysis of some metabolic biomarkers with HPLC-MS/MS revealed in the OP group a 1.4-fold decrease in the concentration of 3-hydroxybutyrate (p<0.05, AUC=0.62) and 1.6-fold decrease in the concentration of 2-hydroxybutyrate (p<0.0001, AUC=0.72). In the OP group, a 26% decrease in acetyl-L-carnitine concentration was found (p<0.001, AUC=0.69). An additional study of the esterase profile of patients revealed a decrease in the activity of butyrylcholinesterase (BChE) by 14% (p<0.05, AUC=0.62) though increase in the esterase activity of albumin by 29% (p<0.05, AUC=0.62) in the OP group. Correlation analysis revealed the most significant relationships between albumin esterase activity and arachidonic acid concentration in the OP group (0.64, p<0.0001). A study of a wide range of fatty acids in patients with OP revealed reciprocal relationships between EFA and NEFA. A decrease in concentration was shown for esters of margaric (p<0.01, AUC=0.65), stearic (p<0.01, AUC=0.65), eicosadienoic (p<0.01, AUC=0.63), eicosatrienoic (p<0.01, AUC=0.66), arachidonic (p<0.001, AUC=0.67), eicosapentaenoic (p<0.05, AUC=0.60), and docosahexaenoic (p<0.0001, AUC=0.74) fatty acids. An increase in the concentration was shown for free (non-esterified) fatty acids: heptadecenoic (p<0.0001, AUC=0.72), eicosapentaenoic (p<0.05, AUC=0.62), eicosatrienoic (p<0.001, AUC=0.68), docosahexaenoic (p<0.01, AUC=0.66), γ-linolenic (p<0.01, AUC=0.66), myristic (p<0.0001, AUC=0.71), eicosenoic (p<0.01, AUC=0.65), arachidonic (p<0.01, AUC=0.66), eicosadienoic (p<0.001, AUC=0.67), oleic (p<0.01, AUC=0.66), linoleic (p<0.01, AUC=0.65), palmitic (p<0.001, AUC=0.68), linoelaidic (p<0.01, AUC=0.65), stearic (p<0.01, AUC=0.64), palmitoleic (p<0.05, AUC=0.61), pentadecanoic (p<0.05, AUC=0.61), and margaric (p<0.01, AUC=0.64). Decrease in the ratios of omega-3 to other unsaturated fatty acids were observed only for the esterified forms: by 29% for n3/n6 (p<0.0001, AUC=0.70), by 33% for n3/(n6+n9) (p<0.0001, AUC=0.72), and by 26% for n3/(all fatty acids) (p<0.0001, AUC=0.72). Finally, we have found out how the most reliable indicators correlate with each other. The esterified docosahexaenoic acid – lactate dehydrogenase (LDH) (0.67, p <0.0001) and LDH – total antioxidant status (TAS) (-0.61, p <0.0001) correlations are stronger in the OP group compared to the correlation in the overall sample and lose their strength and statistical significance in the control group. In the OP group, esterified docosahexaenoic fatty acid, LDH activity, and TAS concentration have a moderate correlation with calcium concentration (-0.66, p <0.0001; -0.67, p <0.0001; 0.63, p <0.0001, respectively). In the control group, this correlation is significantly weakened. Esterified docosahexaenoic acid in the OP group also demonstrated strong positive correlations with a row of other esterified fatty acids, though these correlations were not significantly weakened in the control group. Conclusions: The data obtained allow us to consider an increased level of NEFA as one of the main cytotoxic factors for the vascular endothelium, which can determine the specificity of age-related diseases. Modification of albumin properties by arachidonic acid decreased bioavailability of docosahexaenoic acid could be molecular links that cause specific manifestations of OP-induced pathology at late stages after exposure. Epigenetic changes, the contribution of...

Verified
Journal Article
Open access
PDF file
EKEkaterina Korf
Ekaterina Korf
ANArtem V. Novozhilov
Artem V. Novozhilov
Igor MindukshevIgor Mindukshev
Igor Mindukshev
Andrey Sergeevich GlotovAndrey Sergeevich Glotov
Andrey Sergeevich Glotov
Igor KudryavtsevIgor Kudryavtsev
Igor Kudryavtsev
NGNikolay Goncharov
Nikolay Goncharov
The study of drugs of natural origin that increase endurance and/or accelerate recovery is an integral part of sports medicine and physiology. In this paper, decaffeinated green tea extract (GTE) and two ammonium salts—chloride (ACL) and carbonate (ACR)—were tested individually and in combination with GTE as stimulants of physical performance in a forced swimming rat experimental model. The determined parameters can be divided into seven blocks: functional (swimming duration); biochemistry of blood plasma; biochemistry of erythrocytes; hematology; immunology; gene expression of slow- and fast-twitch muscles (m. soleus, SOL, and m. extensor digitorum longus, EDL, respectively); and morphometric indicators of slow- and fast-twitch muscles. Regarding the negative control (intact animals), the maximum number of changes in all blocks of indicators was recorded in the GTE + ACR group, whose animals showed the maximum functional result and minimum lactate values on the last day of the experiment. Next, in terms of the number of changes, were the groups ACR, ACL, GTE + ACL, GTE and NaCl (positive control). In general, the number of identified adaptive changes was proportional to the functional state of the animals of the corresponding groups, in terms of the duration of the swimming load in the last four days of the experiment. However, not only the total number but also the qualitative composition of the identified changes is of interest. The results of a comparative analysis suggest that, in the model of forced swimming we developed, GTE promotes restoration of the body and moderate mobilization of the immune system, while small doses of ammonium salts, especially ammonium carbonate, contribute to an increase in physical performance, which is associated with satisfactory restoration of skeletal muscles and the entire body. The combined use of GTE with ammonium salts does not give a clearly positive effect.